EQT completed the acquisition of a majority stake in CluePoints.

EQT, a private equity firm, completed the acquisition of a majority stake in CluePoints, a cloud-based software platform for risk-based quality management and data quality oversight in clinical trials. Financial terms were not disclosed. "We are delighted that EQT has chosen to partner with CluePoints. EQT is a market-leading investor in both SaaS (Software as a Service) and medical research industries. This combination makes EQT an ideal partner for CluePoints which is a market leader for SaaS-based clinical data analytics. We are grateful for Summit's active support over the last four years. Their depth of industry knowledge and operational resources have been instrumental in our growth trajectory. Both EQT and Summit share our passion for and commitment to leveraging innovative advanced statistics and machine learning solutions to eliminate manual, error-prone activities in the clinical trial process," Andy Cooper, CluePoints CEO.